SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-22-008745
Filing Date
2022-08-15
Accepted
2022-08-15 06:01:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS admp_defa14a-09012.htm DEFA14A 24879
  Complete submission text file 0001387131-22-008745.txt   25981
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36242 | Film No.: 221162070
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences